Beta glucan is a type of soluble fiber found naturally in a variety of food sources, such as oats, barley, and rye. It’s associated with numerous health benefits, including lower cholesterol levels ...

Beta blockers—drugs commonly prescribed for a range of cardiac conditions, including heart attacks—provide no clinical benefit for patients who have had an uncomplicated myocardial infarction with ...

One way or another, beta blockers are always in the news. Take, for instance, Los Angeles Chargers Head Coach Jim Harbaugh, who revealed in October that he's part of a growing group of Americans who ...

Beta blockers may provide no clinical benefit to patients who maintain normal heart function following a heart attack, according to a study published Aug. 30 in The New England Journal of Medicine.

Please provide your email address to receive an email when new articles are posted on . Beta-blocker use after heart attack in patients with preserved or mildly reduced heart function was assessed in ...

UNDATED (WKRC/CNN Newsource) - Recent research indicates that beta blockers, long used as a first-line treatment after heart attacks, may not benefit the majority of patients and could even increase ...

September 14, 2009 (Barcelona, Spain) — For patients on beta blockade for chronic heart failure who are then hospitalized with acute decompensation and who don't need inotropes like dobutamine, it ...

As is the case with any medication, beta blockers can lead to some side effects. The NHS website urges people to “contact ...

Variety of Non-Proprietary Medicine Bottles and Large Pills on Reflective Surface With Grey Background. A common heart attack drug doesn’t help many patients, clinical trial results show People whose ...

The appropriate duration of beta-blocker treatment after a heart attack (a myocardial infarction [MI]) is unknown in patients who do not need to take beta-blockers for another reason. In the ABYSS ...

Beta blockers are go-to meds for many people who've survived a heart attack. However, new Swedish research has found that they might not be needed for heart attack survivors whose hearts have retained ...

Madrid, Spain – 30 August 2025: Beta-blocker therapy significantly reduced a composite endpoint of all-cause mortality and major adverse cardiovascular events compared with no beta-blocker therapy in ...